Cargando…

Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p

BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Liangxiang, Chen, Anqun, Gao, Qing, Xu, Bo, Guo, Xiaodan, Guan, Tianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925175/
https://www.ncbi.nlm.nih.gov/pubmed/35291969
http://dx.doi.org/10.1186/s12882-022-02732-8
_version_ 1784670014075305984
author Xiao, Liangxiang
Chen, Anqun
Gao, Qing
Xu, Bo
Guo, Xiaodan
Guan, Tianjun
author_facet Xiao, Liangxiang
Chen, Anqun
Gao, Qing
Xu, Bo
Guo, Xiaodan
Guan, Tianjun
author_sort Xiao, Liangxiang
collection PubMed
description BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS), a FDA approved medication for interstitial cystitis, protects diabetic renal fibrosis. METHODS: Cell viability and apoptosis were evaluated in mouse mesangial cells (SV40-MES13) after incubating with the advanced glycation end products (AGEs), which play important roles in the pathogenesis of DN. Western blot and ELISA were performed to determine the expression of transforming growth factor-beta1 (TGF-β1) and fibronectin (FN), two biomarkers of renal fibrosis, as well as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα), two biomarkers of inflammation. The miRNA-mRNA regulatory network involved in the phosphatidylinositol 3-kinase (PI3K)/Ser and Thr Kinase (AKT) signalling was investigated by miRNA deep sequencing and validated by RT-PCR and miRNA transfection. RESULTS: AGEs significantly inhibited cell proliferation and promoted cell apoptosis, which was associated with the overexpression of TGF-β1, FN, IL-6, and TNFα. PPS almost completely reversed AGEs-induced biomarkers of fibrosis and inflammation, and significantly altered the miRNA expression profile in AGEs-treated cells. Notably, the PI3K/AKT signalling was one of the most significantly enriched pathways targeted by PPS-related differentially expressed miRNAs. PPS significantly up-regulated miR-466a-3p, which was shown to target PIK3CA, and mediated the inhibitory effect of PPS on AGEs-induced activation of PI3K/AKT pathway. CONCLUSIONS: The treatment of PPS protected against AGEs-induced toxicity in SV40 MES13 cells via miR-466a-3p-mediated inhibition of PI3K/AKT pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02732-8.
format Online
Article
Text
id pubmed-8925175
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89251752022-03-23 Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p Xiao, Liangxiang Chen, Anqun Gao, Qing Xu, Bo Guo, Xiaodan Guan, Tianjun BMC Nephrol Research BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS), a FDA approved medication for interstitial cystitis, protects diabetic renal fibrosis. METHODS: Cell viability and apoptosis were evaluated in mouse mesangial cells (SV40-MES13) after incubating with the advanced glycation end products (AGEs), which play important roles in the pathogenesis of DN. Western blot and ELISA were performed to determine the expression of transforming growth factor-beta1 (TGF-β1) and fibronectin (FN), two biomarkers of renal fibrosis, as well as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα), two biomarkers of inflammation. The miRNA-mRNA regulatory network involved in the phosphatidylinositol 3-kinase (PI3K)/Ser and Thr Kinase (AKT) signalling was investigated by miRNA deep sequencing and validated by RT-PCR and miRNA transfection. RESULTS: AGEs significantly inhibited cell proliferation and promoted cell apoptosis, which was associated with the overexpression of TGF-β1, FN, IL-6, and TNFα. PPS almost completely reversed AGEs-induced biomarkers of fibrosis and inflammation, and significantly altered the miRNA expression profile in AGEs-treated cells. Notably, the PI3K/AKT signalling was one of the most significantly enriched pathways targeted by PPS-related differentially expressed miRNAs. PPS significantly up-regulated miR-466a-3p, which was shown to target PIK3CA, and mediated the inhibitory effect of PPS on AGEs-induced activation of PI3K/AKT pathway. CONCLUSIONS: The treatment of PPS protected against AGEs-induced toxicity in SV40 MES13 cells via miR-466a-3p-mediated inhibition of PI3K/AKT pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02732-8. BioMed Central 2022-03-15 /pmc/articles/PMC8925175/ /pubmed/35291969 http://dx.doi.org/10.1186/s12882-022-02732-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xiao, Liangxiang
Chen, Anqun
Gao, Qing
Xu, Bo
Guo, Xiaodan
Guan, Tianjun
Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
title Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
title_full Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
title_fullStr Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
title_full_unstemmed Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
title_short Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
title_sort pentosan polysulfate ameliorates fibrosis and inflammation markers in sv40 mes13 cells by suppressing activation of pi3k/akt pathway via mir-446a-3p
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925175/
https://www.ncbi.nlm.nih.gov/pubmed/35291969
http://dx.doi.org/10.1186/s12882-022-02732-8
work_keys_str_mv AT xiaoliangxiang pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p
AT chenanqun pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p
AT gaoqing pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p
AT xubo pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p
AT guoxiaodan pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p
AT guantianjun pentosanpolysulfateamelioratesfibrosisandinflammationmarkersinsv40mes13cellsbysuppressingactivationofpi3kaktpathwayviamir446a3p